Teva Pharmaceutical Industries LimitedTEVANYSE
Loading
Debt to Equity Over TimeNormalizing
Percentile Rank64
3Y CAGR-7.0%
5Y CAGR-3.6%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-7.0%/yr
vs +8.6%/yr prior
5Y CAGR
-3.6%/yr
Recent deceleration
Acceleration
-15.5pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.20 | -34.7% |
| 2024 | 3.36 | +25.3% |
| 2023 | 2.68 | -1.7% |
| 2022 | 2.73 | +19.6% |
| 2021 | 2.28 | -13.3% |
| 2020 | 2.63 | +34.5% |
| 2019 | 1.96 | -0.5% |
| 2018 | 1.97 | +5.1% |
| 2017 | 1.87 | +74.2% |
| 2016 | 1.07 | - |